Sort
48,018 grants matching “immunotherapy”
Biospecimen Unit
$607,324Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2019 · CA
Biospecimen Unit
$607,324Eliezer M Van Allen · Dana-Farber Cancer Inst · U2C · FY2022 · CA
Biospecimen Unit
$607,324Bruce E. Johnson · Dana-Farber Cancer Inst · U2C · FY2020 · CA
Development of a 3D multi-modal perfusion-thermal electrode system
$607,252Xiaoming Yang · University Of Washington · R01 · FY2021 · EB
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$607,228Gerald V Denis · Boston University Medical Campus · R01 · FY2022 · CA
Translational Regulation of T Regulatory Cells
$607,202Robert Schneider · New York University School Of Medicine · R01 · FY2019 · AI
Immunotherapy via engineered therapeutic programs in tumors using RNA
$607,159Ron Weiss · Massachusetts Institute Of Technology · U01 · FY2024 · CA
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$607,124Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2022 · CA
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure
$607,121Vadim Backman · Northwestern University · R01 · FY2022 · CA
Cancer Immunotherapy Clinical Trials
$607,000Christopher Heery · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Non-invasive imaging of the anti-tumor immune response
$606,892Hidde L Ploegh · Boston Children'S Hospital · R01 · FY2021 · CA
Autoimmunity in Cardiopulmonary Toxicities from Radiotherapy andImmunotherapy
$606,856Bo Lu · University Of Missouri-Columbia · R01 · FY2023 · CA
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
$606,797Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Structural and functional characterization of T and NK cell receptors
$606,739Peter D. Sun · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Suppressing the Co-chaperone UNC45A reprograms the immunosuppressive tumor microenvironment to fight Cancer
$606,697Ahmed Chadli · Augusta University · R01 · FY2024 · CA
Bhlhe40 Regulation of T Cell Function During Cancer Immunotherapy
$606,635Matthew M. Gubin · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Bhlhe40 Regulation of T Cell Function During Cancer Immunotherapy
$606,635Matthew M. Gubin · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
T Cell Alloreactivity and Organ Transplant Risk Stratification Models Using High-Resolution HLA and Genomic Data
$606,609Gerald Patrick Morris · University Of California, San Diego · U01 · FY2025 · AI
Study interactions between lung microbiota and immune cells in NSCLC
$606,600Chen Zhao · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
A unique strategy for reshaping the antibiotics model: chemokine-inspired therapeutics for targeting the host and pathogen to counter infections caused by multidrug-resistant bacteria
$606,542Molly A Hughes · University Of Virginia · R01 · FY2022 · AI
Immunologic Control of Drug-resistant HIV-1
$606,435University Of California San Francisco · R01 · FY2003 · AI
Translational Regulation of T Regulatory Cells
$606,410Robert Schneider · New York University School Of Medicine · R01 · FY2022 · AI
Targeting Fibroblast Discoidin Domain Receptor 2 for Immunotherapy to Pulmonary Fibrosis
$606,273Kevin Keewoun Kim · University Of Michigan At Ann Arbor · R01 · FY2023 · HL
ONCOLYTIC SINGLE-CYCLE REPLICATING IMMUNOTHERAPIES FOR KIDNEY CANCER...NEW AWARD
$606,190Mayo Clinic · · FY2019 · Defense Health Agency
Core C: Clinical Management and Resources
$606,178Igor Puzanov · Roswell Park Cancer Institute Corp · P01 · FY2020 · CA